The Pages section of GPnotebook comprises more than 30,000 concise, interlinked clinical reference articles, each focused on a specific primary care topic.
In this month’s selection of content from GPnotebook, three important topics are covered. I begin with an emerging concern about glucagon-like peptide-1 (GLP-1) medicines and vision. I also consider whether changing a mother’s diet during pregnancy can prevent food allergy in her child. And I finish with a deceptively simple question: could drinking your tea or coffee too hot increase your risk of oesophageal cancer?
These short discussions are intended as starting points rather than comprehensive reviews. Follow the link at the end of each discussion to explore the evidence and its implications for clinical practice in more detail.
GLP-1 medicines and NAION – is there a risk to vision?
The remarkable growth in the use of GLP-1-based therapies such as semaglutide and tirzepatide has inevitably increased interest in their less common adverse effects. One that has attracted particular attention is non-arteritic anterior ischaemic optic neuropathy (NAION), an uncommon but potentially devastating condition causing sudden, usually painless and often permanent visual loss.
It is important to distinguish this emerging concern from the early worsening of diabetic retinopathy sometimes seen following a rapid and substantial improvement in glycaemic control. This phenomenon has long been recognised with intensive glucose lowering and is particularly relevant in people with pre-existing diabetic retinopathy and markedly elevated HbA1c. It is not considered a direct toxic effect of GLP-1 receptor agonists on the retina. NAION is quite different: it results from acute ischaemic injury to the optic nerve. Although both issues have attracted attention with the increasing use of potent GLP-1 therapies, they involve different parts of the eye, different pathological processes and a different evidence base.
Several retrospective studies have reported an association between semaglutide and NAION, raising the possibility of a previously unrecognised ocular adverse effect. Other studies, however, have found either no significant association or only a small increase in risk. Interpretation is particularly difficult because many established risk factors for NAION, including diabetes, obesity, dyslipidaemia and increasing age, are also common among people prescribed GLP-1 therapies.
In a short video posted on GPnotebook, Lisa Devine discusses a recent review by Feng and colleagues looking at this evolving evidence and highlighting just how uncertain the relationship remains.
The available data are predominantly observational and cannot establish causation. Adding further complexity, experimental evidence suggests that GLP-1 signalling may actually have neuroprotective effects within the nervous system.
So, is NAION a genuine but rare adverse effect of GLP-1 therapy, an association produced by the characteristics of the patients receiving these drugs, or something more complicated?
For clinicians increasingly prescribing these medicines, this is an emerging safety question worth following. The review, as discussed in Lisa’s short video, provides an accessible starting point for understanding the evidence, its limitations and the important questions that remain unanswered.
Can a mother’s diet reduce food allergy in her baby?
Early introduction of allergenic foods such as peanut and egg during infancy can reduce the risk of food allergy in susceptible children. But could prevention begin even earlier, by increasing a mother’s exposure to these foods during pregnancy and breastfeeding?
A large multicentre randomised trial published in the New England Journal of Medicine, and discussed on GPnotebook here, investigated this question in more than 2000 pregnant women whose babies were considered at increased risk of allergic disease. Mothers were assigned either to substantially increase their consumption of eggs and peanuts during pregnancy and early breastfeeding or to continue a more standard intake.
Despite the biological plausibility of the approach, increasing maternal consumption did not significantly reduce the development of immunoglobulin-E-mediated egg or peanut allergy in the infants at 1 year.
The findings help clarify an increasingly important area of allergy prevention. While early introduction of allergenic foods directly to infants has changed clinical practice, simply increasing maternal exposure during pregnancy and breastfeeding does not appear to provide the same protection.
See this page on GPnotebook for more information about the research, results and implications for food allergy prevention.
Could your tea or coffee be too hot?
Most discussions about tea and coffee focus on what is in the cup. But could the temperature of the drink itself influence cancer risk?
A recent study in the International Journal of Cancer, and described on GPnotebook here, examined this question using data from around 1 million UK adults participating in the Million Women Study and UK Biobank. Over more than a decade of follow-up, researchers examined the relationship between participants’ preferred temperature for hot drinks and their subsequent risk of oesophageal cancer.
The findings are certainly thought-provoking. People who described their drinks as “very hot” had around three times the risk of oesophageal squamous cell carcinoma compared with those who preferred them “warm”. Interestingly, the same relationship was not seen for oesophageal adenocarcinoma, suggesting that repeated thermal injury to the oesophageal mucosa may be important.
There is an important caveat: nobody measured the temperature of participants’ tea or coffee. “Warm”, “hot” and “very hot” were entirely self-reported preferences, making it difficult to translate the findings into a specific safe drinking temperature.
Nevertheless, with hot drinks such an everyday habit, the study raises an intriguing and potentially modifiable risk factor. How strong is the evidence, does the number of hot drinks matter, and should we be advising patients to let their tea or coffee cool before drinking it? For more on the evidence, see this page on GPnotebook.
To receive monthly highlights by email, check your email newsletter preference settings.